Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus

World Journal of Gastroenterology

Volumn 19, Issue 15, 2013, Pages 2395-2403

  Zhang, Hui ^a   Gao, Chun ^a   Fang, Long ^a   Yao, Shu Kun ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Chinese patients; Coagulation function; Diabetes mellitus; Hepatocellular carcinoma; International normalized ratio

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING DISORDER; CANCER STAGING; CHINESE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

EID: 84876566606     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i15.2395     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16 [PMID: 15508102 DOI: 10.1053/j.gastro.2004.09.011]
3. Zhang H, Gao C, Fang L, Zhao HC, Yao SK. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol 2013; 48: 78-87 [PMID: 23137049 DOI: 10.3109/00365521.2012.719926]
4. Gao C, Zhao HC, Li JT, Yao SK. Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol 2010; 16: 4467-4475 [PMID: 20845516 DOI: 10.3748/wjg.v16. i35.4467]
5. Gao C, Yao SK. Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 2009; 8: 465-473 [PMID: 19822488]
6. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491 [PMID: 19224838 DOI: 10.1200/JCO.2008.20.7753]
7. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012; 10: 1342-1359. e2 [PMID: 23041539 DOI: 10.1016/ j.cgh.2012.10.001]
8. Bühler S, Bartenschlager R. Promotion of hepatocellular carcinoma by hepatitis C virus. Dig Dis 2012; 30: 445-452 [PMID: 23108300 DOI: 10.1159/000341688]
9. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851 [PMID: 18328931 DOI: 10.1016/S0140-6736(08)60383-9]
10. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468 [PMID: 14762783 DOI: 10.1053/j.gastro.2003.10.065]
11. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295-1302 [PMID: 16729295 DOI: 10.1002/hep.21208]
12. Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010; 52: 155-163 [PMID: 20578004 DOI: 10.1002/hep.23641]
13. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-539 [PMID: 15753540 DOI: 10.1136/ gut.2004.052167]
14. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-380 [PMID: 16527702 DOI: 10.1016/j.cgh.2005.12.007]
15. Noto H, Osame K, Sasazuki T, Noda M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications 2010; 24: 345-353 [PMID: 20656522 DOI: 10.1016/j.jdiacomp.2010.06.004]
16. Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 2012; 28: 109-122 [PMID: 21898753 DOI: 10.1002/dmrr.1291]
17. Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and metaanalysis of cohort studies. Int J Cancer 2012; 130: 1639-1648 [PMID: 21544812 DOI: 10.1002/ijc.26165]
18. Zhou XH, Qiao Q, Zethelius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CD, Heine RJ, Jousilahti P, Ruotolo G, Nilsson PM, Calori G, Tuomilehto J. Diabetes, prediabetes and cancer mortality. Diabetologia 2010; 53: 1867-1876 [PMID: 20490448 DOI: 10.1007/s00125-010-1796-7]
19. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27: 1567-1571 [PMID: 9620328]
20. Shau WY, Shao YY, Yeh YC, Lin ZZ, Kuo R, Hsu CH, Hsu C, Cheng AL, Lai MS. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist 2012; 17: 856-862 [PMID: 22622151 DOI: 10.1634/theoncologist.2012-0065]
21. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 2011; 6: e27326 [PMID: 22205924 DOI: 10.1371/journal.pone.0027326]
22. Ustuner Z, Akay OM, Keskin M, Kuş E, Bal C, Gulbas Z. Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography. Med Oncol 2012; 29: 3125-3128 [PMID: 22696065 DOI: 10.1007/ s12032-012-0274-0]
23. Zucker S, Cao J. New wrinkle between cancer and blood coagulation: metastasis and cleavage of von Willebrand factor by ADAM28. J Natl Cancer Inst 2012; 104: 887-888 [PMID: 22636799]
24. Kocatürk B, Versteeg HH. Tissue factor isoforms in cancer and coagulation: may the best isoform win. Thromb Res 2012; 129 (Suppl 1): S69-S75 [PMID: 22682138 DOI: 10.1016/ S0049-3848(12)70020-8]
25. Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, Mackman N. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 2012; 119: 5543-5552 [PMID: 22547577 DOI: 10.1182/blood-2012-01-402156]
26. Miyamoto Y, Takikawa Y, De Lin S, Sato S, Suzuki K. Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation. Hepatol Res 2004; 29: 167-172 [PMID: 15203081 DOI: 10.1016/j.hepres.2004.03.011]
27. Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis. Clin Appl Thromb Hemost 2012; 18: 409-415 [PMID: 22166587 DOI: 10.1177/1076029611427900]
28. Madan R, Gupt B, Saluja S, Kansra UC, Tripathi BK, Guliani BP. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India 2010; 58: 481-484 [PMID: 21189694]
29. Banga JD. Coagulation and fibrinolysis in diabetes. Semin Vasc Med 2002; 2: 75-86 [PMID: 16222598 DOI: 10.1055/ s-2002-23098]
30. Dayer MR, Mard-Soltani M, Dayer MS, Alavi SM. Interpretation of correlations between coagulation factors FV, FVIII and vWF in normal and type 2 diabetes mellitus patients. Pak J Biol Sci 2011; 14: 552-557 [PMID: 22032085 DOI: 10.3923/pjbs.2011.552.557]
31. Saad WE, Darwish WM, Davies MG, Kumer S, Anderson C, Waldman DL, Schmitt T, Matsumoto AH, Angle JF. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol 2013; 200: 210-218 [PMID: 23255764 DOI: 10.2214/AJR.11.7653]
32. Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, Chang FY, Lee SD. Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 2004; 99: 1479-1487 [PMID: 15307864 DOI: 10.1111/j.1572-0241.2004.30024.x]
33. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl 1): S64-S71 [PMID: 22187472 DOI: 10.2337/dc12-s064]
34. Boden G, Vaidyula VR, Homko C, Cheung P, Rao AK. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose. J Clin Endocrinol Metab 2007; 92: 4352-4358 [PMID: 17785358 DOI: 10.1210/jc.2007-0933]
35. Breitenstein A, Tanner FC, Lüscher TF. Tissue factor and cardiovascular disease: quo vadis? Circ J 2010; 74: 3-12 [PMID: 19996531 DOI: 10.1253/circj.CJ-09-0818]
36. Tarantino G, Savastano S, Colao A. Hepatic steatosis, lowgrade chronic inflammation and hormone/growth factor/ adipokine imbalance. World J Gastroenterol 2010; 16: 4773-4783 [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773]
37. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009; 21: 504-511 [PMID: 19318968 DOI: 10.1097/MEG.0b013e3283229b40]